A new gold standard. Pending drugs could slow progression of Parkinson's.
Paul
K J
KJ
D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017277:Drug Approval; D006801:Humans; D010300:Parkinson Disease / Q000188:drug therapy*; D014481:United States
D000978:Antiparkinson Agents